Proteus mirabilis is a Gram-negative, rod-shaped bacterium known for its swarming motility and urease activity . It is a frequent cause of catheter-associated urinary tract infections (CAUTIs) . These infections are often polymicrobial and can lead to urolithiasis, the formation of bladder or kidney stones, due to the alkalinization of urine from urease-catalyzed urea hydrolysis . P. mirabilis utilizes various virulence factors to colonize the urinary tract, including urease and the ability to form stones .
Fumarate reductase is an enzyme that catalyzes the interconversion of fumarate and succinate . In P. mirabilis, fumarate reductase allows the bacterium to operate a reductive, branched tricarboxylic acid (TCA) cycle, especially in the absence of succinate dehydrogenase . While fumarate reductase (FrdA) is not required for swarming under all tested conditions, it may play a role in specific scenarios, such as in sdhB mutants under conditions of excess malate or glutamine . The frdD gene encodes one of the subunits of the fumarate reductase enzyme complex in P. mirabilis .
FrdD is a subunit of the fumarate reductase enzyme . Fumarate reductase is a membrane-bound enzyme that is part of the succinate dehydrogenase/fumarate reductase complex, which functions in both the citric acid cycle and anaerobic respiration . The frdD gene in P. mirabilis is designated as PMI3585 in the KEGG database and 529507.PMI3585 in STRING .
P. mirabilis exhibits swarming motility, a coordinated surface migration that is important for its pathogenesis . The TCA cycle plays a role in this swarming behavior . Mutants with aberrant TCA cycle function, such as fumC, show decreased swarming in response to arginine and ornithine . The addition of malate can complement the swarming defect of the fumC mutant, indicating that excess malate promotes a complete oxidative TCA cycle .
Antibiotic resistance in P. mirabilis is a significant concern, complicating the treatment of infections . Resistance mechanisms include transferable plasmids, insertion sequences, transposons, and integrons . Integrons, which are often located on mobile plasmids, facilitate the horizontal gene transfer of resistance genes, including those encoding resistance to β-lactams, aminoglycosides, and quinolones . Multidrug-resistant (MDR) P. mirabilis strains are increasingly prevalent, leading to public health concerns . The ability of P. mirabilis to form crystalline MDR biofilms is a major factor in recurrent CAUTIs .
P. mirabilis produces several virulence factors that contribute to its pathogenicity, including swarming motility, fimbriae, urease production, capsule polysaccharide, and efflux pumps . Biofilm formation is a multistage process involving reversible adhesion, irreversible attachment, microcolony formation, and mature biofilm development . Biofilm-embedded cells are more resistant to antimicrobial treatment and host immune responses compared to planktonic cells .
Two distinct, membrane-bound, FAD-containing enzymes catalyze the interconversion of fumarate and succinate: fumarate reductase (anaerobic growth) and succinate dehydrogenase (aerobic growth). Fumarate reductase subunit D anchors the catalytic components of the fumarate reductase complex to the inner cell membrane and binds quinones.
KEGG: pmr:PMI3585
STRING: 529507.PMI3585
Proteus mirabilis forms fumarate reductase under anaerobic growth conditions, where it plays a critical role in anaerobic respiration. This enzyme catalyzes the reduction of fumarate to succinate, allowing P. mirabilis to use fumarate as a terminal electron acceptor when oxygen is unavailable. The formation of this reductase is repressed under conditions where electron transport to oxygen or nitrate is possible, demonstrating its specialized role in anaerobic adaptation . The fumarate reductase system enables P. mirabilis to survive in oxygen-limited environments such as the urinary tract, particularly during catheter-associated infections where biofilm formation creates oxygen gradients.
The frdD subunit functions as one of the membrane-anchoring proteins in the fumarate reductase complex. The complete fumarate reductase typically consists of four subunits: FrdA (flavoprotein), FrdB (iron-sulfur protein), and FrdC and FrdD (membrane anchor proteins). Spectral investigation of P. mirabilis cytoplasmic membranes revealed the presence of multiple cytochromes, including at least two types of cytochrome b, cytochrome a1, and cytochrome d . FrdD, along with FrdC, anchors the catalytic subunits (FrdA and FrdB) to the cytoplasmic membrane, facilitating electron transfer through the membrane during anaerobic respiration.
While the search results don't specifically detail the genetic organization of the frd operon in P. mirabilis, research indicates that P. mirabilis has complex genetic regulation systems, particularly for factors involved in anaerobic metabolism. Similar to other Enterobacteriaceae, the frd genes in P. mirabilis are likely organized in an operon structure that is regulated by oxygen availability and potentially by other environmental signals. P. mirabilis is known to acquire genes through transferable plasmids, insertion sequences, transposons, and integrons , suggesting that the regulation and genetic context of the frd operon may be subject to horizontal gene transfer and regulatory adaptation.
For membrane proteins like frdD, E. coli-based expression systems with tight regulation are typically most effective. When expressing recombinant P. mirabilis frdD, researchers should consider the following system characteristics:
| Expression System | Advantages | Challenges | Recommended Applications |
|---|---|---|---|
| E. coli BL21(DE3) | High yield, well-established protocols | Possible inclusion body formation | Initial expression screening |
| E. coli C41/C43 | Specialized for membrane proteins | Lower yields than BL21 | Difficult-to-express membrane proteins |
| E. coli Lemo21 | Tunable expression level | Requires optimization | Fine-tuning expression levels |
| Cell-free systems | Avoids toxicity issues | Higher cost, lower yield | Highly toxic membrane proteins |
The expression should be conducted under controlled anaerobic conditions to mimic the natural environment where fumarate reductase is expressed in P. mirabilis .
As a membrane protein, frdD requires specific solubilization and purification strategies:
Membrane preparation: Cytoplasmic membrane suspensions can be isolated from anaerobically grown cultures by differential centrifugation .
Solubilization: Mild detergents like n-dodecyl-β-D-maltoside (DDM) or lauryl maltose neopentyl glycol (LMNG) at concentrations just above their critical micelle concentration are recommended.
Purification: A two-step purification using nickel affinity chromatography followed by size exclusion chromatography typically yields the purest protein.
Buffer optimization: Buffers containing 20-50 mM phosphate or Tris at pH 7.2-7.6 with 100-150 mM NaCl provide stability.
Throughout purification, it's essential to maintain the protein in a detergent micelle environment to prevent aggregation and maintain native-like structure.
Several complementary techniques can assess the integrity of purified frdD:
Circular dichroism (CD) spectroscopy to evaluate secondary structure content
Thermal shift assays to assess protein stability
Reconstitution into liposomes followed by functional assays
Assessment of interaction with other fumarate reductase subunits
For functional verification, researchers can measure electron transport activities in reconstituted systems using formate or NADH as electron donors and fumarate as the acceptor. Inhibitors like 2-n-heptyl-4-hydroxyquinoline-N-oxide and antimycin A can be used to verify the specific electron transport pathway .
While specific structural data for P. mirabilis frdD is not explicitly detailed in the search results, comparative analysis with homologous proteins would likely reveal:
Hydrophobic transmembrane helices that anchor the protein in the cytoplasmic membrane
Conserved residues involved in interaction with FrdC and the catalytic subunits
Structural elements that facilitate menaquinone binding, which plays a crucial role in the fumarate/formate pathway
Spectroscopic techniques have shown that P. mirabilis cytoplasmic membranes contain multiple cytochromes, including cytochrome b, which is directly involved in electron transport to fumarate. Cytochrome b was found to be reduced by both NADH and formate to approximately 80% , suggesting a key role in the electron transport chain that includes frdD.
The frdD subunit, along with FrdC, provides a membrane anchor for the catalytic components and participates in the electron transport chain. In P. mirabilis, experimental evidence suggests that:
The preferential route for electron transport from formate and NADH to fumarate includes cytochrome b as a directly involved carrier .
Menaquinone plays a more exclusive role in the formate/fumarate pathway than in electron transport to oxygen, as demonstrated by UV-irradiation experiments on cytoplasmic membrane suspensions .
The inhibition of respiratory activity by HQNO and antimycin A occurs at the oxidation side of cytochrome b , indicating the position of this component in the electron transport chain.
These findings suggest that frdD likely interacts with menaquinone and contributes to the formation of a functional quinone-binding site within the fumarate reductase complex.
Based on the research methodologies described in the literature, several spectroscopic approaches are valuable:
Absorption spectroscopy to monitor cytochrome reduction states during electron transport
EPR (Electron Paramagnetic Resonance) spectroscopy to characterize iron-sulfur clusters and their interaction with the membrane components
FTIR (Fourier-Transform Infrared) spectroscopy to examine protein-lipid interactions
Fluorescence spectroscopy with labeled quinone analogs to study binding kinetics
The expression of fumarate reductase in P. mirabilis is tightly regulated by oxygen availability. Research has demonstrated that:
P. mirabilis forms fumarate reductase specifically under anaerobic growth conditions .
The formation of this reductase is repressed when electron transport to oxygen or nitrate is possible .
This oxygen-responsive regulation ensures that the energetically less favorable fumarate respiration is only activated when necessary.
The specific molecular mechanisms of this regulation in P. mirabilis are not fully detailed in the search results, but likely involve oxygen-sensing transcription factors similar to those in related Enterobacteriaceae, such as FNR (fumarate and nitrate reduction regulator) and ArcAB (aerobic respiration control) two-component system.
Fumarate reductase plays a crucial role in P. mirabilis adaptation to oxygen-limited environments, such as those encountered during urinary tract infections. The ability to use fumarate as a terminal electron acceptor allows P. mirabilis to:
Maintain energy production through anaerobic respiration when oxygen is limited
Colonize the deeper layers of biofilms where oxygen is scarce
Survive in catheter-associated urinary tract infections where biofilm formation creates anaerobic niches
P. mirabilis is known to cause between 1-10% of all urinary tract infections and is especially prevalent in catheter-associated UTIs (10-44% of long-term CAUTIs) . The ability to grow anaerobically using fumarate respiration likely contributes to this pathogen's persistence in these environments.
While the search results don't specifically address mutations in frdD, research on chlorate-resistant mutant strains of P. mirabilis provides some insights. In two of three tested chlorate-resistant mutant strains, fumarate reductase appeared to be affected , suggesting that:
Mutations affecting fumarate reductase components, potentially including frdD, can impact the ability to use fumarate as an electron acceptor
Such mutations may have pleiotropic effects on anaerobic metabolism
The bacterial fitness cost of these mutations likely depends on environmental conditions
The specific effects of frdD mutations would need to be assessed through careful phenotypic analysis, including growth rate measurements under various anaerobic conditions and competitive fitness assays against wild-type strains.
Creating genetic modifications in P. mirabilis presents unique challenges compared to model organisms. Recommended approaches include:
Allelic exchange using suicide vectors containing counterselectable markers
CRISPR-Cas9 systems adapted for P. mirabilis
Transposon mutagenesis followed by screening for frdD disruptions
When designing these experiments, researchers should consider P. mirabilis' natural resistance mechanisms and potential barriers to genetic manipulation. P. mirabilis acquires genes encoding antimicrobial resistance via transferable plasmids, insertion sequences, transposons, and integrons , which provides insight into potential vectors for genetic engineering.
To distinguish direct frdD effects from polar effects:
Create in-frame, scarless deletions that don't affect downstream gene expression
Complement the mutation with wild-type frdD expressed from a plasmid or different chromosomal location
Perform qRT-PCR to verify expression levels of other frd operon genes in the mutant
Create site-directed mutations that alter function without affecting expression
Additionally, researchers should consider the possibility of compensatory changes in other electron transport components when interpreting phenotypes of frdD mutants.
Advanced transcriptomic methods to elucidate frdD regulation include:
RNA-Seq under varying oxygen levels and growth conditions
ChIP-Seq to identify transcription factors binding to the frd operon promoter
5' RACE to precisely map transcription start sites
Ribosome profiling to assess translational regulation
These approaches can reveal how P. mirabilis coordinates frdD expression with other components of anaerobic metabolism and identify potential novel regulators specific to this organism's unique lifestyle and environmental adaptations.
While the search results don't directly connect fumarate reductase to virulence, there's indirect evidence suggesting potential contributions:
P. mirabilis is capable of causing symptomatic infections of the urinary tract including cystitis and pyelonephritis .
The ability to thrive anaerobically would provide an advantage in the oxygen-limited environment of urinary biofilms.
P. mirabilis infections can lead to stone formation (urolithiasis) , which may be influenced by metabolic activities including anaerobic respiration.
To directly test this connection, researchers would need to compare the virulence of wild-type P. mirabilis with fumarate reductase mutants in animal models of urinary tract infection. Such experiments could assess bacterial burden, tissue damage, and the formation of crystalline biofilms.
Several mechanisms could connect frdD to antibiotic tolerance:
Anaerobic growth mediated by fumarate reductase may reduce the efficacy of antibiotics that target actively dividing cells.
Metabolic adaptation through alternative electron acceptors may help bacteria survive during antibiotic stress.
The membrane localization of frdD might influence membrane permeability to certain antibiotics.
P. mirabilis has been shown to develop resistance to multiple antibiotics, including extended-spectrum beta-lactams, cephalosporins, fluoroquinolones, and aminoglycosides . While not specifically linked to fumarate reductase, these resistance mechanisms demonstrate the adaptability of this pathogen and suggest that metabolic flexibility could contribute to survival under antibiotic pressure.
Biofilm formation is a key virulence factor in P. mirabilis, particularly in catheter-associated UTIs. While not explicitly addressed in the search results, fumarate reductase likely contributes to biofilm metabolism through:
Enabling growth in the oxygen-limited depths of mature biofilms
Contributing to the metabolic heterogeneity within biofilm populations
Potentially influencing the extracellular matrix composition through altered metabolite production
Further research using biofilm models and comparing wild-type to fumarate reductase mutants would be needed to fully elucidate this relationship. The swarming behavior of P. mirabilis, another key aspect of its pathogenesis , might also be influenced by metabolic adaptations involving fumarate reductase.
The membrane-associated fumarate reductase complex represents a potential target for novel antimicrobials based on several factors:
It is essential for anaerobic growth, which is relevant to infection sites
The membrane localization makes it potentially accessible to drugs
Structural differences from mammalian enzymes could allow selective targeting
Potential therapeutic approaches could include:
Small molecule inhibitors targeting the quinone binding site
Peptides disrupting the assembly of the fumarate reductase complex
Compounds that interfere with electron transfer between subunits
The increasing prevalence of antibiotic resistance in P. mirabilis (48% of strains exhibiting resistance) underscores the need for novel therapeutic targets like the fumarate reductase complex.
Advanced techniques for studying membrane protein interactions include:
Cross-linking mass spectrometry (XL-MS) to capture in situ interactions
Förster resonance energy transfer (FRET) with fluorescently labeled subunits
Cryo-electron microscopy of the intact complex
Native mass spectrometry of the purified complex
Hydrogen-deuterium exchange mass spectrometry (HDX-MS) to identify interaction surfaces
These techniques can reveal how frdD interacts with other fumarate reductase subunits and potentially with other membrane components involved in electron transport. The interaction with menaquinone, which plays a more exclusive role in the formate/fumarate pathway , would be of particular interest.
Systems biology approaches can place frdD within the broader context of P. mirabilis metabolism:
These approaches can help researchers understand how P. mirabilis coordinates central carbon metabolism, electron transport chains, and energy production during transitions between aerobic and anaerobic conditions. Such insights could reveal new vulnerabilities for therapeutic targeting and explain this pathogen's remarkable adaptability in diverse host environments.